MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/1871527319666200518102130

Медицинская библиотека · CNS & neurological disorders drug targets · 2020

Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches.

Bhattamisra Subrat Kumar, Shin Lee Yuen, Saad Hanis Izzati Binti Mohd, Rao Vikram, Candasamy Mayuren, Pandey Manisha, Choudhury Hira

СтатьяОбзорПеревод пока не подготовлен

Аннотация

The interlink between diabetes mellitus and neurodegenerative diseases such as Alzheimer's Disease (AD) and Parkinson's Disease (PD) has been identified by several researchers. Patients with Type-2 Diabetes Mellitus (T2DM) are found to be affected with cognitive impairments leading to learning and memory deficit, while patients with Type-1 Diabetes Mellitus (T1DM) showed less severe levels of these impairments in the brain. This review aimed to discuss the connection between insulin with the pathophysiology of neurodegenerative diseases (AD and PD) and the current therapeutic approached mediated through insulin for management of neurodegenerative diseases. An extensive literature search was conducted using keywords "insulin"; "insulin resistance"; "Alzheimer's disease"; "Parkinson's disease" in public domains of Google scholar, PubMed, and ScienceDirect. Selected articles were used to construct this review. Studies have shown that impaired insulin signaling contributes to the accumulation of amyloid-β, neurofibrillary tangles, tau proteins and α-synuclein in the brain. Whereas, improvement in insulin signaling slows down the progression of cognitive decline. Various therapeutic approaches for altering the insulin function in the brain have been researched. Besides intranasal insulin, other therapeutics like PPAR-γ agonists, neurotrophins, stem cell therapy and insulin-like growth factor-1 are under investigation. Research has shown that insulin insensitivity in T2DM leads to neurodegeneration through mechanisms involving a variety of extracellular, membrane receptor, and intracellular signaling pathway disruptions. Some therapeutics, such as intranasal administration of insulin and neuroactive substances have shown promise but face problems related to genetic background, accessibility to the brain, and invasiveness of the procedures.

Для цитирования: Bhattamisra Subrat Kumar, Shin Lee Yuen, Saad Hanis Izzati Binti Mohd, Rao Vikram, Candasamy Mayuren, Pandey Manisha, Choudhury Hira. Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches.. CNS & neurological disorders drug targets. 2020. DOI: 10.2174/1871527319666200518102130.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.